• Login
    View Item 
    •   HPS Repository Home
    • Embryo Project Encyclopedia
    • Embryo Project Articles
    • View Item
    •   HPS Repository Home
    • Embryo Project Encyclopedia
    • Embryo Project Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Leuprorelin as a Treatment for Endometriosis

    Thumbnail
    View/Open
    ConLeuprorelinEndometriosisES.xhtml (11.96Kb)
    Author
    Santora, Emily
    Guerrero, Anna
    Metadata
    Show full item record
    Abstract
    Leuprolide acetate, or leuprorelin, is a manufactured drug that has been prescribed as a treatment for endometriosis, a medical condition in which body tissue that typically lines the uterus grows outside of the uterus, since 1989. Leuprorelin is a modified version of a gonadotropin-releasing hormone, a type of hormone that helps regulate the female menstrual cycle. The drug inhibits the production of estrogen, a female sex hormone that enables endometrial gland growth. After two weeks of injections, leuprorelin stops the production of estrogen, and without estrogen, endometrial glands become inactive. That decreases the growth of uterine tissue outside of the uterus, which helps decrease the pain associated with endometriosis. Although physicians commonly prescribe leuprorelin as of 2019, women with endometriosis have reported adverse side effects and health complications.
    URI
    https://hpsrepository.asu.edu/handle/10776/13136
    Collections
    • Embryo Project Articles

    Browse

    All of HPS RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister
    DSpace software Copyright © 2015  Duraspace
    Contact Us | Send Feedback